SCHEMBL6002255

SCHEMBL6002255

[CH2]COC(=O)N(C)c1cccc(Cl)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TSHR P16473 1/20 0.35
SCN9A Q15858 1/20 0.34
GPR142 Q7Z601 1/20 0.34
HTT P42858 1/20 0.34
ATM Q13315 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2089971 0.86 ALDH1A1 (0.47) RXRARXRBRXRGALDH1A1LMNA
SCHEMBL6003085 0.78 PTGIR (0.39) RXRARXRBRXRGALDH1A1KMT2A
SCHEMBL2089969 0.77 RXRA (0.37) RXRARXRBRXRGALDH1A1LMNA
SCHEMBL6003215 0.76 SIGMAR1 (0.54) ALDH1A1LMNASIGMAR1
SCHEMBL6002450 0.76 PTGIR (0.39) LMNASMN1; SMN2KMT2ASCN9ACHRNB2
SCHEMBL2093311 0.75 TSHR (0.42) RXRARXRBRXRGALDH1A1MEN1
SCHEMBL2093314 0.75 TSHR (0.47) RXRARXRBRXRGALDH1A1LMNA
SCHEMBL17513418 0.75 FSCN1 (0.53) RXRARXRBRXRGALDH1A1LMNA
SCHEMBL2091261 0.75 DDB1 (0.40) ALDH1A1SMN1; SMN2MEN1KMT2ATSHR
SCHEMBL2093891 0.75 CHRNB2 (0.36) ALDH1A1LMNASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed